Status:
COMPLETED
An Investigational Study of Cyclosporine on Experimental Medication BMS-986165 in Healthy Male Participants
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Psoriasis
Eligibility:
MALE
18-50 years
Phase:
PHASE1
Brief Summary
This is an investigational study of Cyclosporine on the experimental medication BMS-986165 in healthy male participants.
Eligibility Criteria
Inclusion
- For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com
- Healthy participant, as determined by no clinically significant deviation from normal in medical history, physical examination, ECGs, and clinical laboratory determinations
- Body mass index 18.0 to 32.0 kg/m2
- Weight ≥ 50 kg
Exclusion
- Any medical condition that presents a potential risk to the subject and/or may compromise the objectives of the study, including a history of or active liver disease
- History or presence of acute or chronic bacterial, fungal, or viral infection (eg, pneumonia, septicemia) within the 3 months prior to screening
- Known or suspected autoimmune disorder, or any history of known or suspected congenital or acquired immunodeficiency state or condition that would compromise the participant's immune status
- History of administration of live vaccines within 60 days before screening
- Any history or risk for tuberculosis (TB)
- Other protocol defined inclusion/exclusion criteria could apply
Key Trial Info
Start Date :
March 5 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 4 2018
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT03419910
Start Date
March 5 2018
End Date
May 4 2018
Last Update
March 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
PRA Health Sciences
Salt Lake City, Utah, United States, 84124